Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	answer text
creator	label
publisher	pref label
tabling member	label

Search

1091369

	human indexable
	published
	registered interest
	answer date	21/03/2019
	date	19/03/2019
	date tabled	19/03/2019
	ddp created	19/03/2019 19:53:09
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	19/03/2019 20:00:41 27/03/2019 16:14:02
	hansard heading	5G: Health Hazards
	house id	1
	identifier	234268
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	27/03/2019 15:42:52
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of the roll-out of 5G technology on people's health.
	session	2017/19
	session number	1
	tabling member constituency	Cheltenham
	tabling member printed	Alex Chalk
	title	House of Commons Tabled Parliamentary Question 2017/19 234268
	type	WrittenParliamentaryQuestion
	uin	234268
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Electromagnetic fields (EMFs) and health evidence reviews have been prepared by scientific expert groups in the United Kingdom and around the world. The independent Advisory Group on Non-Ionising Radiation (AGNIR) published their report in the UK in 2012 and the European Commission’s Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) published their report in 2015. The World Health Organization is presently preparing a review. The AGNIR report is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/radiofrequency-electromagnetic-fields-health-effects" target="_blank">https://www.gov.uk/government/publications/radiofrequency-electromagnetic-fields-health-effects</a></p><p> </p><p>The SCENIHR report is available at the following link:</p><p> </p><p><a href="https://ec.europa.eu/health/sites/health/files/scientific_committees/docs/citizens_emf_en.pdf" target="_blank">https://ec.europa.eu/health/sites/health/files/scientific_committees/docs/citizens_emf_en.pdf</a></p><p> </p><p>Based on the accumulated evidence and reviews, Public Health England (PHE) advises that the guidelines of the International Commission on Non-Ionizing Radiation Protection (ICNIRP) should be adopted and there is no convincing evidence that EMF exposures below the ICNIRP guideline levels cause adverse health effects.</p><p> </p><p>PHE has committed to keeping the emerging evidence under review and to preparing another comprehensive review when sufficient new evidence has accumulated.</p>
	creator	4481 label Biography information for Alex Chalk
	publisher	25259 pref label House of Commons
	tabling member	4481 label Biography information for Alex Chalk

1105060

	human indexable
	published
	registered interest
	answer date	26/03/2019
	date	26/03/2019
	date tabled	26/03/2019
	ddp created	26/03/2019 13:26:06
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/03/2019 13:38:17 26/03/2019 14:37:01
	hansard heading	Alcoholic Drinks: Misuse
	house id	1
	identifier	910044
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	26/03/2019 14:04:44
	question text	What steps he is taking to support children living with alcohol-dependent parents.
	session	2017/19
	session number	1
	tabling member constituency	Congleton
	tabling member printed	Fiona Bruce
	title	House of Commons Tabled Parliamentary Question 2017/19 910044
	type	WrittenParliamentaryQuestion
	uin	910044
	version	1
	written parliamentary question type	NamedDay
	answer	answer answer text <p>Alcohol addiction has a devastating impact on individuals and their families and it is unacceptable that children bear the brunt of their parents’ condition.</p><p>This is why we have set up a £6 million three-year programme to improve outcomes for vulnerable children living with alcohol dependent parents.</p>
	creator	3958 label Biography information for Fiona Bruce
	publisher	25259 pref label House of Commons
	tabling member	3958 label Biography information for Fiona Bruce

1092719

	human indexable
	published
	registered interest
	answer date	25/03/2019
	date	21/03/2019
	date tabled	21/03/2019
	ddp created	21/03/2019 18:24:28
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	21/03/2019 18:43:10 29/03/2019 15:11:03
	hansard heading	Alcoholism and Drugs: Rehabilitation
	house id	1
	identifier	235390
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	29/03/2019 14:38:57
	question text	To ask the Secretary of State for Health and Social Care, what proportion of NHS spending is allocated to drug and alcohol rehabilitation services.
	session	2017/19
	session number	1
	tabling member constituency	Tooting
	tabling member printed	Dr Rosena Allin-Khan
	title	House of Commons Tabled Parliamentary Question 2017/19 235390
	type	WrittenParliamentaryQuestion
	uin	235390
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>In the financial year 2017-18 the estimated total cost to National Health Service trusts and NHS foundation trusts for providing rehabilitation for drug and alcohol addiction is £572,000. The majority of drug and alcohol services fall under the remit of local authorities who are responsible for assessing local need and commissioning services to meet identified needs, including for drug and alcohol dependence, using the ringfenced public health grant.</p>
	creator	4573 label Biography information for Dr Rosena Allin-Khan
	publisher	25259 pref label House of Commons
	tabling member	4573 label Biography information for Dr Rosena Allin-Khan

1105287

	human indexable
	published
	registered interest
	answer date	28/03/2019
	date	26/03/2019
	date tabled	26/03/2019
	ddp created	26/03/2019 21:38:22
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/03/2019 22:16:50 03/04/2019 11:58:01
	hansard heading	Alopecia
	house id	1
	identifier	237079
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	03/04/2019 11:25:38
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people in the UK who suffer with mental health as a consequence of alopecia.
	session	2017/19
	session number	1
	tabling member constituency	Shipley
	tabling member printed	Philip Davies
	title	House of Commons Tabled Parliamentary Question 2017/19 237079
	type	WrittenParliamentaryQuestion
	uin	237079
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>This information is not collected.</p>
	creator	1565 label Biography information for Sir Philip Davies
	publisher	25259 pref label House of Commons
	tabling member	1565 label Biography information for Sir Philip Davies

1105290

	human indexable
	published
	registered interest
	answer date	28/03/2019
	date	26/03/2019
	date tabled	26/03/2019
	ddp created	26/03/2019 21:38:30
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/03/2019 22:16:57 02/04/2019 16:18:11
	hansard heading	Alopecia
	house id	1
	identifier	237081
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	02/04/2019 15:45:24
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people who have been diagnosed with alopecia in the UK.
	session	2017/19
	session number	1
	tabling member constituency	Shipley
	tabling member printed	Philip Davies
	title	House of Commons Tabled Parliamentary Question 2017/19 237081
	type	WrittenParliamentaryQuestion
	uin	237081
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Information concerning the number of people diagnosed with alopecia is not available.</p><p> </p><p>The National Institute of Health and Care Excellence states that alopecia is a relatively common condition, estimated to affect 15 in 10,000 people in the United Kingdom. Alopecia can present at any age, and males and females are affected equally.</p><p> </p><p>Information concerning the cost to the National Health Service regarding the provision of wigs for alopecia is not available.</p>
	creator	1565 label Biography information for Sir Philip Davies
	publisher	25259 pref label House of Commons
	tabling member	1565 label Biography information for Sir Philip Davies

1105291

	human indexable
	published
	registered interest
	answer date	28/03/2019
	date	26/03/2019
	date tabled	26/03/2019
	ddp created	26/03/2019 21:38:33
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/03/2019 22:16:59 02/04/2019 16:18:09
	hansard heading	Alopecia
	house id	1
	identifier	237082
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	02/04/2019 15:45:24
	question text	To ask the Secretary of State for Health and Social Care, how much the NHS has spent on providing wigs to patients diagnosed with alopecia in each of the last three years for which information is available.
	session	2017/19
	session number	1
	tabling member constituency	Shipley
	tabling member printed	Philip Davies
	title	House of Commons Tabled Parliamentary Question 2017/19 237082
	type	WrittenParliamentaryQuestion
	uin	237082
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Information concerning the number of people diagnosed with alopecia is not available.</p><p> </p><p>The National Institute of Health and Care Excellence states that alopecia is a relatively common condition, estimated to affect 15 in 10,000 people in the United Kingdom. Alopecia can present at any age, and males and females are affected equally.</p><p> </p><p>Information concerning the cost to the National Health Service regarding the provision of wigs for alopecia is not available.</p>
	creator	1565 label Biography information for Sir Philip Davies
	publisher	25259 pref label House of Commons
	tabling member	1565 label Biography information for Sir Philip Davies

1092659

	human indexable
	published
	registered interest
	answer date	25/03/2019
	date	21/03/2019
	date tabled	21/03/2019
	ddp created	21/03/2019 18:17:41
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	22/03/2019 12:15:15 29/03/2019 15:11:14
	hansard heading	Antibiotics: Drug Resistance
	house id	1
	identifier	235308
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	29/03/2019 14:35:37
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Tackling antimicrobial resistance 2019–2024: The UK’s five-year national action plan, published on 24 January 2019, what plans he has to fund the (a) design and (b) testing of a new economic model for antibiotics.
	session	2017/19
	session number	1
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2017/19 235308
	type	WrittenParliamentaryQuestion
	uin	235308
	version	2
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The project to develop and test the feasibility of new models that pay companies for antimicrobials based primarily on a heath technology assessment of their value to the National Health Service as opposed to the volumes used, and to share the learning with international stakeholders, is expected to be established by July this year.</p><p> </p><p>The NHS Long Term Plan, published in January this year, makes the commitment to implement the human health aspects of ‘Tackling Antimicrobial Resistance (2019-2024): the UK’s five-year national action plan’. The project will be led by a central project team resourced by the National Institute for Health and Care Excellence and NHS England and the National Institute for Health Research Policy Research Programme is considering research to support the process.</p>
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1104898

	human indexable
	published
	registered interest
	answer date	27/03/2019
	date	25/03/2019
	date tabled	25/03/2019
	ddp created	26/03/2019 00:23:59
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/03/2019 01:15:53 02/04/2019 12:13:08
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	identifier	236296
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	02/04/2019 11:37:31
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle the increase in anti-microbial resistance.
	session	2017/19
	session number	1
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Mr David Davis
	title	House of Commons Tabled Parliamentary Question 2017/19 236296
	type	WrittenParliamentaryQuestion
	uin	236296
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Building on the achievements in the UK Five Year in Antimicrobial Resistance (AMR) Strategy (2013-2018), the Government published ‘Contained and controlled: The UK’s 20-year vision for antimicrobial resistance’ and ‘Tackling Antimicrobial Resistance (2019-2024): The UK’s five-year national action plan’ on 24 January 2019. The two documents set out the United Kingdom’s vision for a world in which AMR in contained and controlled by 2040 and challenging five-year ambitions that will begin to fulfil the vision.</p><p> </p><p>The Department will coordinate work across Government and its agencies to implement the national action plan, and the UK Government will continue to play its part as a global leader in tackling the problem of AMR by modelling best practice at home and supporting progress internationally.</p><p> </p><p>More information on the UK’s vision and national action plan can be found at the following links:</p><p> </p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773065/uk-20-year-vision-for-antimicrobial-resistance.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773065/uk-20-year-vision-for-antimicrobial-resistance.pdf</a></p><p> </p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773130/uk-amr-5-year-national-action-plan.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773130/uk-amr-5-year-national-action-plan.pdf</a></p>
	creator	373 label Biography information for Sir David Davis
	publisher	25259 pref label House of Commons
	tabling member	373 label Biography information for Sir David Davis

1091207

	human indexable
	published
	registered interest
	answer date	21/03/2019
	date	19/03/2019
	date tabled	19/03/2019
	ddp created	19/03/2019 19:39:24
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	20/03/2019 15:26:12 27/03/2019 13:20:33
	hansard heading	Asthma: Prescriptions
	house id	1
	identifier	234138
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	27/03/2019 12:44:24
	question text	To ask the Secretary of State for Health and Social Care, what the clinical rationale is to charge people with asthma for their prescription charges when people with many other long-term conditions are exempt from paying.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 234138
	type	WrittenParliamentaryQuestion
	uin	234138
	version	2
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The Department has made no assessment on the effect of prescription charges on the young people with asthma and on the incidence of asthma attacks in England. The Department has made no estimate of the number of people with asthma who have missed their medication due to the cost of a prescription. Extensive arrangements are in place to help people afford NHS prescriptions. These include a broad range of prescription charge exemptions, for which someone with asthma may qualify.</p><p> </p><p>The Department has no current plans to amend these exemptions, including the list of medical conditions that provides exemption from prescription charges. Children under 16, and students under the age of 19 and in qualifying full-time education are also exempt from prescription charges. People on a low income, who do not qualify for an exemption, may be eligible for full or partial help with prescription charges through application to the NHS Low Income Scheme.</p><p> </p><p>To support those with greatest need who do not qualify for an exemption or the NHS Low Income Scheme, prescription prepayment certificates are available. A holder of a 12-month certificate can get all the prescriptions they need for just £2 per week.</p>
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1091208

	human indexable
	published
	registered interest
	answer date	21/03/2019
	date	19/03/2019
	date tabled	19/03/2019
	ddp created	19/03/2019 19:39:26
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	19/03/2019 19:45:38 27/03/2019 13:20:31
	hansard heading	Asthma: Prescriptions
	house id	1
	identifier	234139
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	27/03/2019 12:44:24
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of prescription charges on young people with asthma.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 234139
	type	WrittenParliamentaryQuestion
	uin	234139
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The Department has made no assessment on the effect of prescription charges on the young people with asthma and on the incidence of asthma attacks in England. The Department has made no estimate of the number of people with asthma who have missed their medication due to the cost of a prescription. Extensive arrangements are in place to help people afford NHS prescriptions. These include a broad range of prescription charge exemptions, for which someone with asthma may qualify.</p><p> </p><p>The Department has no current plans to amend these exemptions, including the list of medical conditions that provides exemption from prescription charges. Children under 16, and students under the age of 19 and in qualifying full-time education are also exempt from prescription charges. People on a low income, who do not qualify for an exemption, may be eligible for full or partial help with prescription charges through application to the NHS Low Income Scheme.</p><p> </p><p>To support those with greatest need who do not qualify for an exemption or the NHS Low Income Scheme, prescription prepayment certificates are available. A holder of a 12-month certificate can get all the prescriptions they need for just £2 per week.</p>
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon